rs1033214914
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP2PP3BS2
The NM_001127222.2(CACNA1A):c.6266G>A(p.Arg2089Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000297 in 1,613,488 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. R2089R) has been classified as Likely benign.
Frequency
Consequence
NM_001127222.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1A | NM_001127222.2 | c.6266G>A | p.Arg2089Gln | missense_variant | 43/47 | ENST00000360228.11 | NP_001120694.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1A | ENST00000360228.11 | c.6266G>A | p.Arg2089Gln | missense_variant | 43/47 | 1 | NM_001127222.2 | ENSP00000353362.5 | ||
CACNA1A | ENST00000638029.1 | c.6284G>A | p.Arg2095Gln | missense_variant | 44/48 | 5 | ENSP00000489829.1 | |||
CACNA1A | ENST00000573710.7 | c.6272G>A | p.Arg2091Gln | missense_variant | 43/47 | 5 | ENSP00000460092.3 | |||
CACNA1A | ENST00000635727.1 | c.6269G>A | p.Arg2090Gln | missense_variant | 43/47 | 5 | ENSP00000490001.1 | |||
CACNA1A | ENST00000637769.1 | c.6269G>A | p.Arg2090Gln | missense_variant | 43/47 | 1 | ENSP00000489778.1 | |||
CACNA1A | ENST00000636012.1 | c.6269G>A | p.Arg2090Gln | missense_variant | 43/46 | 5 | ENSP00000490223.1 | |||
CACNA1A | ENST00000637736.1 | c.6128G>A | p.Arg2043Gln | missense_variant | 42/46 | 5 | ENSP00000489861.1 | |||
CACNA1A | ENST00000636389.1 | c.6269G>A | p.Arg2090Gln | missense_variant | 43/47 | 5 | ENSP00000489992.1 | |||
CACNA1A | ENST00000637432.1 | c.6284G>A | p.Arg2095Gln | missense_variant | 44/48 | 5 | ENSP00000490617.1 | |||
CACNA1A | ENST00000636549.1 | c.6275G>A | p.Arg2092Gln | missense_variant | 44/48 | 5 | ENSP00000490578.1 | |||
CACNA1A | ENST00000637927.1 | c.6272G>A | p.Arg2091Gln | missense_variant | 43/47 | 5 | ENSP00000489715.1 | |||
CACNA1A | ENST00000635895.1 | c.6269G>A | p.Arg2090Gln | missense_variant | 43/47 | 5 | ENSP00000490323.1 | |||
CACNA1A | ENST00000638009.2 | c.6269G>A | p.Arg2090Gln | missense_variant | 43/47 | 1 | ENSP00000489913.1 | |||
CACNA1A | ENST00000637276.1 | c.6269G>A | p.Arg2090Gln | missense_variant | 43/46 | 5 | ENSP00000489777.1 | |||
CACNA1A | ENST00000636768.1 | n.*568G>A | non_coding_transcript_exon_variant | 8/10 | 5 | ENSP00000490190.2 | ||||
CACNA1A | ENST00000636768.1 | n.*568G>A | 3_prime_UTR_variant | 8/10 | 5 | ENSP00000490190.2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152200Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248096Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134820
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461288Hom.: 0 Cov.: 32 AF XY: 0.0000261 AC XY: 19AN XY: 726954
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152200Hom.: 0 Cov.: 34 AF XY: 0.0000673 AC XY: 5AN XY: 74346
ClinVar
Submissions by phenotype
not provided Uncertain:4
Uncertain significance, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Mar 06, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 15, 2024 | Identified in a patient diagnosed with episodic ataxia type 2 in published literature (PMID: 20663518); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34806130, 20663518) - |
Uncertain significance, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 20, 2024 | Unlikely to be causative of CACNA1A-related spinocerebellar ataxia (AD) or CACNA1A-related neurologic disorder (AD) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Episodic ataxia type 2;C4310716:Developmental and epileptic encephalopathy, 42 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 09, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at